Major shareholders according to SIX Swiss Exchange Disclosure Office
(as of 3 September 2020)
BlackRock, Inc. – 9.67%
Find historical shareholding disclosures on the SIX Exchange Regulation website.
-
Our Offering
-
Pharma & Biotech
Our LPBN segment offers clinical development services, clinical and commercial manufacturing in biologics and small molecule businesses, alongside consumables and research tools.
-
Capsules & Health Ingredients
Our CHI business delivers oral dosage forms alongside nutritional ingredients for the consumer health market.
-
Microbial Control Solutions
Our MCS business delivers future-proof Microbial Control technologies and related applications to consumer-facing and resource protection markets.
-
Specialty Chemical Services
Our SCS business delivers solutions in technically demanding industries and applications, alongside capabilities in custom development and manufacturing.
-
-
About Us
-
Careers
-
Overview
We are here to make a Meaningful Difference. It is the foundation of the way we do business. A career at Lonza is more than a job. We do not just work in the life sciences industries, we are transforming them. What we do today is helping to create a healthier, happier world tomorrow.
-
- Contact